Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01918891 · ClinicalTrials.gov registry record · NA

Center for Stroke Disparities Solution - Community Transitions Intervention

A NA study of Hypertension and Stroke, sponsored by Visiting Nurse Service of New York.

Completed
Registry status
NA
Development phase
495
Enrollment target
1
Study location

NCT01918891 is a NA study of Hypertension and Stroke that has completed, run by Visiting Nurse Service of New York. The registered enrollment target is 495 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01918891, a NA study of Hypertension and Stroke, has completed, sponsored by Visiting Nurse Service of New York.

COMPLETED
Registry status
NA
Development phase
495 participants
Enrollment target
1
Study location

Study Summary

The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.

Interventions

  • BEHAVIORAL Nurse Practitioner Only
  • BEHAVIORAL Nurse Practitioner + Health Coach

Study Locations (1)

New York

  • Visiting Nurse Service of New York - New York

Trial Details

FieldValue
Enrollment Target 495 participants
Start Date 2012-09
Est. Completion 2018-06
Phase NA

What the Registry Record Tells You About NCT01918891

The ClinicalTrials.gov registry entry for NCT01918891 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 495 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The listed sponsor is Visiting Nurse Service of New York, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Nurse Practitioner Only is the first listed.

NCT01918891 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01918891 about?

NCT01918891 is a clinical study titled "Center for Stroke Disparities Solution - Community Transitions Intervention". The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.

What is the current status of trial NCT01918891?

This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2012-09. Estimated completion is 2018-06.

What conditions does trial NCT01918891 study?

This clinical trial studies the following conditions: Hypertension, Stroke, Transient Ischemic Attack.

What interventions are being tested in trial NCT01918891?

The interventions under investigation include: Nurse Practitioner Only (BEHAVIORAL), Nurse Practitioner + Health Coach (BEHAVIORAL).

Who is sponsoring clinical trial NCT01918891?

This trial is sponsored by Visiting Nurse Service of New York, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01918891 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.